Blog

Tom Powles and Giorgio Bogani Discuss the Recently Published Study on Advanced or Recurrent Endometrical Cancer

Photo collage of Tom Powles and Giorgio Bogani taken from their LinkedIn

Jun 15, 2024, 07:36

Tom Powles and Giorgio Bogani Discuss the Recently Published Study on Advanced or Recurrent Endometrical Cancer

The European Society for Medical Oncology (ESMO) posted on LinkedIn:

“Latest podcast Annals of Oncology Editor-in-Chief Tom Powles talks to Giorgio Bogani. They discuss the recently published study considering recent phase III trials that investigated the role of Immunotherapy in the first-line setting for advanced or recurrent Endometrical Cancer.”

Read further.
Source: The European Society for Medical Oncology (ESMO)/LinkedIn

advanced cancer Annals of Oncology cancer Cancer research cancer studies Endometrial cancer ESMO first-line treatment Giorgio Bogani immunotherapy OncoDaily Oncology oncology podcast phase III trials recurrent cancer Tom Powles

Oncologist Near Me - Vivek Subbiah: Pionner of Precision Oncology

Monica Bertagnolli is ending her tenure as NIH director

NEW PAPER ALERT: Efficacy of CDK4/6 Inhibitors and Endocrine Therapy in HR+/HER2- Advanced Breast Cancer by PAM50 Subtype: SOLTI-1801 CDK-PREDICT Results

Oncologist Near Me – Fabrice André: Leading Expert in Breast Cancer

Funding Impactful Cancer Research That Might Otherwise Go Unsupported: Ryan Schoenfeld on the Secret Behind Mark Foundation’s Success

Special Coverage